Total Payments
$11,909
2024 Payments
$1,538
Companies
40
Transactions
848
Medicare Patients
22,549
Medicare Billing
$846,301
Payment Breakdown by Category
Food & Beverage$11,832 (99.4%)
Education$77.38 (0.6%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,832 | 841 | 99.4% |
| Education | $77.38 | 7 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $2,466 | 153 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,975 | 121 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,161 | 79 | $0 (2024) |
| Merck Sharp & Dohme LLC | $822.14 | 84 | $0 (2024) |
| Lilly USA, LLC | $681.61 | 58 | $0 (2024) |
| ABBVIE INC. | $487.77 | 33 | $0 (2024) |
| GlaxoSmithKline, LLC. | $476.43 | 33 | $0 (2024) |
| Astellas Pharma US Inc | $451.68 | 29 | $0 (2021) |
| Bayer Healthcare Pharmaceuticals Inc. | $419.43 | 26 | $0 (2024) |
| Allergan, Inc. | $355.32 | 39 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,538 | 76 | Novo Nordisk Inc ($571.02) |
| 2023 | $1,609 | 91 | Novo Nordisk Inc ($495.35) |
| 2022 | $1,267 | 76 | Novo Nordisk Inc ($358.52) |
| 2021 | $1,546 | 104 | Novo Nordisk Inc ($448.76) |
| 2020 | $366.09 | 26 | Novo Nordisk Inc ($64.43) |
| 2019 | $2,189 | 184 | AstraZeneca Pharmaceuticals LP ($383.62) |
| 2018 | $1,467 | 124 | AstraZeneca Pharmaceuticals LP ($424.02) |
| 2017 | $1,927 | 167 | AstraZeneca Pharmaceuticals LP ($358.78) |
All Payment Transactions
848 individual payment records from CMS Open Payments — Page 1 of 34
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/02/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $26.85 | General |
| Category: Diabetes | ||||||
| 11/25/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.15 | General |
| Category: Cardio-renal | ||||||
| 11/21/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.72 | General |
| Category: DIABETES | ||||||
| 11/20/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $23.96 | General |
| Category: Iron Deficiency Anemia | ||||||
| 11/19/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $24.09 | General |
| Category: NEUROSCIENCE | ||||||
| 11/18/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $24.55 | General |
| Category: Diabetes | ||||||
| 11/12/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $17.60 | General |
| Category: VACCINES | ||||||
| 11/07/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $24.76 | General |
| Category: Iron Deficiency Anemia | ||||||
| 11/05/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $15.61 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/04/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $21.98 | General |
| Category: Obesity | ||||||
| 10/31/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $15.45 | General |
| Category: Respiratory | ||||||
| 10/28/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.66 | General |
| Category: Diabetes | ||||||
| 10/22/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $24.94 | General |
| Category: Diabetes | ||||||
| 10/21/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.76 | General |
| Category: Cardio-renal | ||||||
| 10/17/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.96 | General |
| Category: Diabetes | ||||||
| 10/01/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $19.50 | General |
| Category: Respiratory | ||||||
| 09/26/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $17.17 | General |
| Category: Respiratory | ||||||
| 09/24/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.15 | General |
| Category: Diabetes | ||||||
| 09/19/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.79 | General |
| Category: Cardio-renal | ||||||
| 09/16/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $26.69 | General |
| Category: UROLOGY | ||||||
| 09/10/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $27.00 | General |
| Category: Diabetes | ||||||
| 09/05/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $15.40 | General |
| Category: NEUROSCIENCE | ||||||
| 08/29/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $24.98 | General |
| Category: Diabetes | ||||||
| 08/27/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $24.21 | General |
| Category: Respiratory | ||||||
| 08/22/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 40 | 5,334 | 8,278 | $618,408 | $221,942 |
| 2022 | 39 | 5,662 | 8,429 | $601,530 | $217,737 |
| 2021 | 41 | 5,771 | 8,635 | $619,621 | $227,317 |
| 2020 | 42 | 5,782 | 8,063 | $558,945 | $179,304 |
Total Patients
22,549
Total Services
33,405
Medicare Billing
$846,301
Procedure Codes
162
All Medicare Procedures & Services
162 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 526 | 1,209 | $238,173 | $94,203 | 39.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 360 | 360 | $85,320 | $43,150 | 50.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 489 | 1,132 | $23,772 | $9,509 | 40.0% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 457 | 724 | $41,268 | $9,456 | 22.9% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 489 | 885 | $33,630 | $9,119 | 27.1% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 373 | 438 | $31,974 | $7,209 | 22.5% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 424 | 626 | $21,910 | $4,752 | 21.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 80 | 87 | $11,571 | $4,732 | 40.9% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 58 | 58 | $8,352 | $4,397 | 52.6% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 244 | 454 | $19,522 | $4,297 | 22.0% |
| 87636 | Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19) and influenza virus types a and b | Office | 2023 | 27 | 27 | $9,504 | $3,774 | 39.7% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 21 | 23 | $7,180 | $3,316 | 46.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 47 | 48 | $5,978 | $3,313 | 55.4% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 167 | 174 | $13,746 | $3,135 | 22.8% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 194 | 203 | $10,759 | $2,638 | 24.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 87 | 89 | $3,204 | $2,531 | 79.0% |
| 81003 | Automated urinalysis test | Office | 2023 | 472 | 832 | $11,648 | $1,823 | 15.7% |
| G0328 | Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | Office | 2023 | 87 | 87 | $2,523 | $1,539 | 61.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 135 | 140 | $7,420 | $1,162 | 15.7% |
| 82306 | Vitamin d-3 level | Office | 2023 | 25 | 32 | $3,680 | $928.32 | 25.2% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2023 | 17 | 18 | $1,836 | $905.04 | 49.3% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 41 | 50 | $3,200 | $729.15 | 22.8% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 38 | 44 | $2,552 | $587.84 | 23.0% |
| 72100 | X-ray of lower and sacral spine, 2-3 views | Office | 2023 | 27 | 27 | $1,890 | $480.70 | 25.4% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 48 | 57 | $1,824 | $460.02 | 25.2% |
About Dr. Robert Humphreys, MD
Dr. Robert Humphreys, MD is a Family Medicine healthcare provider based in Germantown, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/07/2006. The National Provider Identifier (NPI) number assigned to this provider is 1295744134.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Humphreys, MD has received a total of $11,909 in payments from pharmaceutical and medical device companies, with $1,538 received in 2024. These payments were reported across 848 transactions from 40 companies. The most common payment nature is "Food and Beverage" ($11,832).
As a Medicare-enrolled provider, Humphreys has provided services to 22,549 Medicare beneficiaries, totaling 33,405 services with total Medicare billing of $846,301. Data is available for 4 years (2020–2023), covering 162 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Germantown, TN
- Active Since 08/07/2006
- Last Updated 05/17/2021
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1295744134
Products in Payments
- FARXIGA (Drug) $1,053
- Ozempic (Drug) $942.55
- JARDIANCE (Drug) $600.42
- Kerendia (Drug) $419.43
- BREZTRI (Drug) $353.34
- JANUVIA (Drug) $317.75
- TRULICITY (Drug) $304.09
- Wegovy (Drug) $302.56
- Vascepa (Drug) $297.11
- BELSOMRA (Drug) $296.22
- Rybelsus (Drug) $289.10
- MOUNJARO (Drug) $259.89
- Myrbetriq (Drug) $236.03
- UBRELVY (Drug) $231.69
- SYMBICORT (Drug) $207.33
- MYRBETRIQ (Drug) $202.06
- Saxenda (Drug) $195.90
- SHINGRIX (Biological) $175.17
- PREVNAR 20 (Biological) $171.22
- XARELTO (Drug) $170.44
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Germantown
William Jackson, Md, MD
Family Medicine — Payments: $99,518
Family Medicine $99,518
Dr. John Crawford, Md, MD
Family Medicine — Payments: $27,065
Family Medicine $27,065
Hugo Caballero, M.d, M.D
Family Medicine — Payments: $16,957
Family Medicine $16,957
Gregory Laurence, Md, MD
Family Medicine — Payments: $11,720
Family Medicine $11,720
Dr. Avni Jain, M.d., M.b.b.s, M.D., M.B.B.S
Family Medicine — Payments: $3,277
Family Medicine $3,277
Dr. Joseluis Jimenez, M.d, M.D
Family Medicine — Payments: $3,153
Family Medicine $3,153